1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Open-Angle Glaucoma Global Clinical Trials Review, H1, 2016

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2016" provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2016
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 28
Prominent Drugs 30
Latest Clinical Trials News on Open-Angle Glaucoma 31
Mar 03, 2016: Aerie Pharmaceuticals Announces Availability on Its Website of Abstracts to be Presented at the American Glaucoma Society 26th Annual Meeting 31
Clinical Trial Profile Snapshots 32
Appendix 371
Abbreviations 371
Definitions 371
Research Methodology 372
Secondary Research 372
About GlobalData 373
Contact Us 373
Disclaimer 373
Source 374

List of Tables
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region, 2016* 6
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2016* 21
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 29
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30

List of Figures
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2016* 15
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16
Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17
Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2016* 18
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19
Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22
Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25
Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28
Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 30
GlobalData Methodology 372

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Glaucoma Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Glaucoma Therapeutics Market: Overview Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results into vision loss and blindness. The treatment for glaucoma ...

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The ophthalmic lasers market is projected to reach USD 1,245.4 million by 2021 from USD 970.2 million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, increasing prevalence of ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.